Literature DB >> 11431685

Consent and privacy in pharmacogenetic testing.

J A Robertson1.   

Abstract

The clinical use of pharmacogenetic drugs will require that a sample of a patient's DNA be tested before a drug is prescribed. Although pharmacogenetic tests pose fewer risks than genetic tests for disease mutations, they might still reveal personal information that could be used adversely to a patient's interests. Informed consent and privacy of pharmacogenetic test results may be essential in most clinical uses of pharmacogenetic drugs.

Entities:  

Keywords:  Genetics and Reproduction; Legal Approach

Mesh：

Year:  2001        PMID： 11431685     DOI： 10.1038/90032

Source DB:  PubMed          Journal:  Nat Genet        ISSN： 1061-4036            Impact factor:   38.330


  12 in total

Review 1.  Ethical reflections on pharmacogenetics and DNA banking in a cohort of HIV-infected patients.

Authors:  Sandrine de Montgolfier; Grégoire Moutel; Nathalie Duchange; Ioannis Theodorou; Christian Hervé; Catherine Leport
Journal:  Pharmacogenetics       Date:  2002-12

2.  Delivering a pharmacogenetic service: is there a role for genetic counselors?

Authors:  Alice Callard; William Newman; Katherine Payne
Journal:  J Genet Couns       Date:  2011-11-04       Impact factor: 2.537

Review 3.  A review of consent practices and perspectives for pharmacogenetic testing.

Authors:  Susanne B Haga; Rachel Mills
Journal:  Pharmacogenomics       Date:  2016-08-17       Impact factor: 2.533

4.  Genetic counselors' (GC) knowledge, awareness, understanding of clinical next-generation sequencing (NGS) genomic testing.

Authors:  P M Boland; K Ruth; J M Matro; K L Rainey; C Y Fang; Y N Wong; M B Daly; M J Hall
Journal:  Clin Genet       Date:  2015-01-22       Impact factor: 4.438

5.  Clinical delivery of pharmacogenetic testing services: a proposed partnership between genetic counselors and pharmacists.

Authors:  Rachel Mills; Susanne B Haga
Journal:  Pharmacogenomics       Date:  2013-06       Impact factor: 2.533

Review 6.  Using pharmacogenetics and pharmacogenomics in the treatment of psychiatric disorders: some ethical and economic considerations.

Authors:  Katherine I Morley; Wayne D Hall
Journal:  J Mol Med (Berl)       Date:  2003-11-04       Impact factor: 4.599

7.  Public attitudes toward ancillary information revealed by pharmacogenetic testing under limited information conditions.

Authors:  Susanne B Haga; Julianne M O'Daniel; Genevieve M Tindall; Isaac R Lipkus; Robert Agans
Journal:  Genet Med       Date:  2011-08       Impact factor: 8.822

Review 8.  Emerging strategies and applications of pharmacogenomics.

Authors:  Patrice M Milos; Albert B Seymour
Journal:  Hum Genomics       Date:  2004-11       Impact factor: 4.639

Review 9.  Understanding the human health effects of chemical mixtures.

Authors:  David O Carpenter; Kathleen Arcaro; David C Spink
Journal:  Environ Health Perspect       Date:  2002-02       Impact factor: 9.031

10.  Delivering pharmacogenetic testing in a primary care setting.

Authors:  Rachel Mills; Deepak Voora; Bruce Peyser; Susanne B Haga
Journal:  Pharmgenomics Pers Med       Date:  2013-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.